D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Walt Disney
DIS
|
+$410M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
GE Aerospace
GE
|
+$196M |
| 5 |
Dell
DELL
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$374M |
| 2 |
PayPal
PYPL
|
+$289M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Nike
NKE
|
+$227M |
| 5 |
Amgen
AMGN
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNCMA
1751
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.41M | ﹤0.01% |
175,273
-26,575
| -13% | -$379K |
|
|
AMRN
1752
Amarin Corp
AMRN
$290M
| $2.41M | ﹤0.01% |
37,755
-14,026
| -27% | -$786K |
|
1753
PUT
United Therapeutics
UTHR
$26.3B
| $2.41M | ﹤0.01% |
20,400
| – | – |
|
1754
ICU Medical
ICUI
$4.04B
| $2.41M | ﹤0.01% |
19,047
+390
| +2% | +$47K |
|
|
SKX
1755
CALL
DELISTED
Skechers
SKX
| $2.4M | ﹤0.01% |
105,000
| – | – |
|
1756
Intrepid Potash
IPI
$461M
| $2.4M | ﹤0.01% |
212,668
-47,109
| -18% | -$617K |
|
|
BITA
1757
PUT
DELISTED
Bitauto Holdings Limited
BITA
| $2.4M | ﹤0.01% |
82,600
-40,000
| -33% | -$1.09M |
|
1758
CALL
Corning
GLW
$123B
| $2.4M | ﹤0.01% |
+101,300
| New | +$2.26M |
|
|
ACTA
1759
DELISTED
Actua Corp
ACTA
| $2.39M | ﹤0.01% |
184,888
+15,960
| +9% | +$162K |
|
|
GPX
1760
DELISTED
GP Strategies Corp.
GPX
| $2.39M | ﹤0.01% |
97,107
+9,211
| +10% | +$214K |
|
1761
Synaptics
SYNA
$4.55B
| $2.39M | ﹤0.01% |
+40,780
| New | +$2.24M |
|
|
FDML
1762
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $2.39M | ﹤0.01% |
248,430
+1,002
| +0.4% | +$9.12K |
|
1763
NN Inc
NNBR
$273M
| $2.38M | ﹤0.01% |
130,683
+35,011
| +37% | +$589K |
|
1764
PUT
Ulta Beauty
ULTA
$20.7B
| $2.38M | ﹤0.01% |
+10,000
| New | +$2.53M |
|
1765
Ventas
VTR
$48.7B
| $2.38M | ﹤0.01% |
+33,690
| New | +$2.45M |
|
|
LIOX
1766
DELISTED
Lionbridge Technologies
LIOX
| $2.38M | ﹤0.01% |
475,101
+76,107
| +19% | +$357K |
|
|
MJN
1767
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.37M | ﹤0.01% |
30,000
+10,000
| +50% | +$853K |
|
|
RYZ
1768
Ryerson Holding Corp
RYZ
$1.59B
| $2.37M | ﹤0.01% |
209,649
+129,012
| +160% | +$1.74M |
|
|
AHRT
1769
AH Realty Trust
AHRT
$536M
| $2.37M | ﹤0.01% |
176,553
+32,004
| +22% | +$448K |
|
1770
CALL
Merck
MRK
$323B
| $2.37M | ﹤0.01% |
39,719
-316,601
| -89% | -$18.5M |
|
|
1771
CALL
United Therapeutics
UTHR
$26.3B
| $2.36M | ﹤0.01% |
20,000
| – | – |
|
|
CSLT
1772
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.36M | ﹤0.01% |
567,600
+130,775
| +30% | +$534K |
|
|
CEB
1773
DELISTED
CEB Inc.
CEB
| $2.36M | ﹤0.01% |
+43,337
| New | +$2.59M |
|
|
GHDX
1774
DELISTED
Genomic Health, Inc.
GHDX
| $2.36M | ﹤0.01% |
81,515
+9,314
| +13% | +$260K |
|
1775
CALL
Herbalife
HLF
$1.26B
| $2.36M | ﹤0.01% |
76,000
+26,000
| +52% | +$821K |
|
Similar funds
D.E. Shaw & Co's Q3 2016 Portfolio in Review
As of Q3 2016, D.E. Shaw & Co held 3,773 positions worth $56.7B, up 4.5% from $54.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2016 filing shows 448 new, 1,212 increased, 1,374 reduced and 429 closed positions. Its largest new stake was Dell: 13,808,231 shares worth $185M. The largest sale was Meta Platforms (Facebook), an estimated $374M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
- D.E. Shaw & Co's largest Q3 2016 buy was Dell: 13,808,231 shares worth $185M.
- D.E. Shaw & Co added most to Apple in Q3 2016, an estimated $453M increase.
- D.E. Shaw & Co's biggest Q3 2016 reduction was Meta Platforms (Facebook), cutting an estimated $374M.
- D.E. Shaw & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $278M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $56.7B portfolio in Q3 2016.
- D.E. Shaw & Co opened 448 new positions and closed 429 in Q3 2016.
- D.E. Shaw & Co's portfolio value rose 4.5% quarter-over-quarter to $56.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.